Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedJun 16, 2026
DataAggregated Company Financials
Companies109
  • 7D5.9%
  • 3M1.8%
  • 1Y-14.6%
  • YTD-7.3%

In the last week, the Personal Products industry is up 5.9%, with Estée Lauder Companies up 6.3%. In the same time, LifeVantage was down 38%. In the past year, the industry is down 15%. Looking forward, earnings are forecast to grow by 33% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Jun 2026US$84.0bUS$48.3bUS$700.6m16.1x120x1.7x
Thu, 14 May 2026US$79.9bUS$48.3bUS$677.0m16.4x118.1x1.7x
Sat, 11 Apr 2026US$76.2bUS$48.2bUS$613.7m20.8x124.2x1.6x
Mon, 09 Mar 2026US$86.4bUS$48.2bUS$789.9m23.4x109.4x1.8x
Wed, 04 Feb 2026US$96.0bUS$47.6bUS$349.9m22x274.4x2x
Fri, 02 Jan 2026US$89.4bUS$47.6bUS$351.1m22.6x254.7x1.9x
Sun, 30 Nov 2025US$86.3bUS$47.6bUS$357.6m23.2x241.4x1.8x
Tue, 28 Oct 2025US$89.5bUS$47.7bUS$290.5m21x308x1.9x
Thu, 25 Sep 2025US$91.7bUS$47.7bUS$298.4m21.5x307.2x1.9x
Sat, 23 Aug 2025US$98.8bUS$47.6bUS$304.6m21.8x324.3x2.1x
Mon, 21 Jul 2025US$100.8bUS$48.0bUS$109.7m18.3x918.6x2.1x
Wed, 18 Jun 2025US$96.9bUS$48.0bUS$108.2m17.5x895x2x
Fri, 16 May 2025US$92.3bUS$48.0bUS$83.9m20.8x1100.2x1.9x
Sun, 13 Apr 2025US$82.7bUS$48.7bUS$554.6m22.9x149.2x1.7x
Tue, 11 Mar 2025US$95.4bUS$49.0bUS$331.4m25.8x287.9x1.9x
Thu, 06 Feb 2025US$91.6bUS$49.0bUS$572.1m26.7x160.1x1.9x
Sat, 04 Jan 2025US$96.3bUS$49.3bUS$1.5b25.6x65.3x2x
Mon, 02 Dec 2024US$103.5bUS$49.3bUS$1.5b29.3x70.2x2.1x
Wed, 30 Oct 2024US$105.7bUS$49.5bUS$1.6b25.9x65.3x2.1x
Fri, 27 Sep 2024US$108.4bUS$49.5bUS$1.6b25.1x66.2x2.2x
Sun, 25 Aug 2024US$112.1bUS$49.5bUS$1.6b21.9x70.4x2.3x
Tue, 23 Jul 2024US$106.7bUS$49.0bUS$2.4b22.2x44.1x2.2x
Thu, 20 Jun 2024US$111.6bUS$49.0bUS$2.4b22.6x46x2.3x
Sat, 18 May 2024US$128.5bUS$48.8bUS$2.5b21.6x52.4x2.6x
Mon, 15 Apr 2024US$120.8bUS$48.8bUS$2.5b25.3x47.6x2.5x
Wed, 13 Mar 2024US$134.5bUS$49.1bUS$2.4b28.7x55.6x2.7x
Fri, 09 Feb 2024US$129.3bUS$49.2bUS$2.6b25.5x50.3x2.6x
Sun, 07 Jan 2024US$124.8bUS$49.9bUS$2.6b25.1x47.4x2.5x
Tue, 05 Dec 2023US$119.7bUS$49.9bUS$2.6b26.8x46x2.4x
Thu, 02 Nov 2023US$100.6bUS$49.7bUS$2.8b23.9x35.5x2x
Sat, 30 Sep 2023US$121.5bUS$50.0bUS$3.3b23.4x36.9x2.4x
Mon, 28 Aug 2023US$132.2bUS$50.0bUS$3.3b20.1x40.4x2.6x
Wed, 26 Jul 2023US$148.5bUS$49.8bUS$3.1b25.6x48.5x3x
Fri, 23 Jun 2023US$153.3bUS$49.3bUS$3.1b23x48.9x3.1x
Price to Earnings Ratio

48.9x


Total Market Cap: US$153.3bTotal Earnings: US$3.1bTotal Revenue: US$49.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 171.9x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 120x which is lower than its 3-year average PE of 172x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 39% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market2.20%
Consumer Staples2.04%
Personal Products5.87%
Personal Products5.87%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$90.006.3%
+US$1.9b		20.7%PS2.2x
KVUE KenvueUS$18.254.0%
+US$1.3b		-15.7%PE21.6x
ELF e.l.f. BeautyUS$63.9922.4%
+US$696.0m		-49.3%PE144.5x
IPAR InterparfumsUS$99.427.6%
+US$225.1m		-27.7%PE18.8x
EPC Edgewell Personal CareUS$22.9913.4%
+US$124.9m		-1.4%PS0.5x

Latest News

PAVS
US$0.19
Paranovus Entertainment Technology
7D
-79.8%
1Y
-99.9%
MEHA
US$0.019
Functional Brands
7D
-56.3%
1Y
n/a
ELF
US$63.99
e.l.f. Beauty
7D
22.4%
1Y
-49.3%
ODD
US$11.56
Oddity Tech
7D
16.4%
1Y
-83.9%
Seeking Alpha • Jun 15

Oddity Tech: Recovery Proof Is Still Missing (Rating Downgrade)

Summary Oddity Tech is downgraded from buy to hold due to unresolved customer acquisition cost headwinds and weak first-order growth. Q1 2026 revenue declined 26% y/y, with first orders down ~50% and margins deteriorating; Q2 guidance suggests continued revenue contraction. The investment thesis now hinges on whether CPA normalization is temporary or structural, as elevated CPA undermines the core acquisition engine. With ODD trading at 24.8x forward P/E and lacking a margin of safety, I recommend waiting for clear evidence of CPA normalization and revenue recovery. Read the full article on Seeking Alpha
LFVN
US$6.61
LifeVantage
7D
-38.2%
1Y
-48.2%
EL
US$90.00
Estée Lauder Companies
7D
6.3%
1Y
20.7%
Narrative Update • Jun 15

EL: Turnaround Progress And Restructuring Charges Will Frame Future Standalone Upside

Analysts have trimmed their price target for Estée Lauder Companies slightly to $95.12 from $95.43. This reflects updated assumptions around revenue growth, profit margins and a modestly higher future P/E multiple.
COTY
US$2.05
Coty
7D
5.7%
1Y
-59.4%
IPAR
US$99.42
Interparfums
7D
7.6%
1Y
-27.7%
Seeking Alpha • Jun 10

Interparfums: A Fine Fragrance Machine, But 2026 Is A Bridge Year

Summary Interparfums remains a high-quality fragrance company with a diversified license portfolio, strong cash flows, and a conservative balance sheet. 2026 guidance projects flat sales ($1.48B) and lower EPS ($4.85), tempering near-term growth expectations and justifying a Hold rating. Q1 2026 results confirmed solid gross margins (65.1%) and cash flow discipline, but operating margins contracted due to rising SG&A expenses. At ~19x 2026E EPS and a base-case fair value of $89, IPAR offers balanced risk/reward; existing holders can wait, but new buyers should seek a better entry or growth clarity. Read the full article on Seeking Alpha
KVUE
US$18.25
Kenvue
7D
4.0%
1Y
-15.7%
Narrative Update • Jun 08

KVUE: Future Returns Will Reflect Merger Progress And Legal Earnings Balance

Analysts slightly lifted their fair value estimate for Kenvue to $19.50, a modest move supported by small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, even as recent Street research from Citi, Barclays and UBS reflects more cautious price targets. Analyst Commentary Recent price target trims of around $1 from several firms signal that the Street is fine tuning expectations rather than making a wholesale shift in its view on Kenvue.
EPC
US$22.99
Edgewell Personal Care
7D
13.4%
1Y
-1.4%
Narrative Update • Jun 06

EPC: Share Repurchases And Updated Outlook Will Drive Future Upside Potential

Analysts have nudged their price target on Edgewell Personal Care from about $24.17 to $24.50, reflecting updated assumptions around discount rates, revenue trends, profit margins and the stock's future P/E. What's in the News Edgewell Personal Care reported that from January 1, 2026 to March 31, 2026, it repurchased 224,000 shares, representing 0.48% of shares, for a total of US$15.01 million under its existing buyback program.
MED
US$11.94
Medifast
7D
-1.1%
1Y
-11.8%
Narrative Update • Jun 06

MED: Leadership Transition And Margin Outlook Will Shape Balanced Future Profile

Analysts have modestly adjusted their price target on Medifast, reflecting updated views on the discount rate, expected profit margins near 8.1%, and an anticipated P/E around 9.7x, which together suggest a slightly different risk and valuation profile for the stock. What's in the News The board has appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026.
BRBR
US$8.86
BellRing Brands
7D
12.2%
1Y
-85.9%
Narrative Update • Jun 04

BRBR: Protein Adoption Trend Will Support Recovery After Recent Earnings Reset

Analysts have cut their price targets on BellRing Brands sharply, with one high profile reduction to $13 from $34 and a series of other target trims and downgrades following a disappointing quarter, rising concerns about competition, and ongoing estimate revisions. Analyst Commentary Recent Street research around BellRing Brands points to a clear reset in expectations, with multiple bearish analysts cutting price targets and, in some cases, downgrading ratings after the latest quarterly report.
NUS
US$5.15
Nu Skin Enterprises
7D
-3.2%
1Y
-35.2%
Analysis Article • May 18

Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues

The market shrugged off Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) solid earnings report. We did some digging and believe...
BNKK
US$1.36
Bonk
7D
-8.7%
1Y
-84.3%
NHTC
US$2.06
Natural Health Trends
7D
-10.3%
1Y
-55.3%
AXIL
US$6.30
AXIL Brands
7D
-6.1%
1Y
16.9%